CE: Overview of the Gestational Diabetes Educational Gap

Erica Hagen

Abstract


A holistic approach to preventing gestational diabetes mellitus (GDM) in pregnant women may decrease the incidence of recurring GDM and type two diabetes mellitus (T2DM) postpartum. The American College of Obstetricians and Gynecologists state that a glucose screening test is generally given to women between 24 and 28 weeks, unless the woman has a history of GDM.Education on preventing GDM for women early in their pregnancy is not standardized, and GDM may not be discussed unless diagnosed. There are few published studies on education for prevention of GDM and its impact on the incidence of T2DM. In addition, postpartum follow-up for blood glucose screening is not well-documented. Further research on these topics may have global impacts.


Full Text:

PDF

Refbacks

  • There are currently no refbacks.


Notice and Disclaimer

Medicine is an ever-changing science.  As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required.  The authors and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication.  However, in view of the possibility of human error or changes in medical sciences, neither the authors nor the publisher nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is accurate or complete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of the information contained in this work.    Readers are encouraged to confirm the information contained herein with other sources.   For example and in particular, readers are advised to check the product information sheet included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.